Pulmonology and Respiratory Medicine conferences host presentations from experts across the world in the field of Pulmonology and Respiratory System. These conferences create awareness and understanding of the work done by the scientists and professors working in the various fields of Pulmonology and Respiratory Medicine like Lung Diseases which deals with study on Significant diseases and their types; Lung Cancer, Asthma, Tuberculosis which deals with the latest research on viruses, prions and other types of diseases to competition against the infections and recent out-breaks of viruses like Asthma; pneumothorax or atelectasis which deals with the current research on Lung related diseases.

Venue: Paris capital is a major European city and a global centre for art, fashion, gastronomy and culture. Its 19th-century cityscape is crisscrossed by wide boulevards and the River Seine. Beyond such landmarks as the Eiffel Tower and the 12th-century, Gothic Notre-Dame cathedral, the city is known for its cafe culture and designer boutiques along the Rue du Faubourg Saint-Honoré. According to the Economist Intelligence Unit Worldwide Cost of Living Survey in 2018, Paris was the second most expensive city in the world, after Singapore, and ahead of Zürich, Hong Kong, Oslo and Geneva.

Paris is famous for its cafe culture, the Eiffel Tower, the Louvre, Notre Dame, the Moulin Rouge, pastries, and fashion. Paris is often seen as having beauty, elegance, and as being a boldly romantic city. As the capital city of France, Paris has endured as an important city for more than 2,000 years. Often called by nicknames like the “city of love” and “city of lights,” Paris is today one of the world’s leading centers for business, fashion, entertainment, art and culture. Just the mere mention of Paris conjures up images of the city’s world famous landmarks, museums and cathedrals. Also called the Capital of Fashion, Paris is home to some of the world’s finest designer names including Yves Saint-Laurent, Lancôme, L’Oréal and Christian Dior.

Sessions/ Tracks

Respiratory Conference 2020 is comprised of various tracks and sessions designed to offer comprehensive sessions that address current issues in the field of Pulmonology and Respiratory Medicine.

Track 1: Chronic Obstructive Pulmonary Disease

Chronic obstructive Pulmonary Disease is a constant incendiary lung illness that causes discouraged wind stream from the lungs. Side effects incorporate breathing trouble, hack, bodily fluid creation and wheezing. It's brought about by long haul introduction to disturbing gases or particulate issue, frequently from tobacco smoke. Individuals with COPD are at expanded danger of creating coronary illness, lung malignancy and an assortment of different conditions. The top reason for COPD is tobacco smoking. Long haul introduction to synthetic aggravations can likewise prompt COPD. It's a sickness that generally sets aside a long effort to create Diagnosis usually involves imaging tests, blood tests, and lung function tests. There's no solution for COPD, yet treatment can help ease manifestations, bring down the opportunity of intricacies, and for the most part improve personal satisfaction. Meds, supplemental oxygen treatment, and medical procedure are a few types of treatment. Early indications incorporate into COPD are incidental brevity of breath, particularly after exercise, mellow however repetitive hack and expecting to make a sound as if to speak regularly, particularly before anything else.

Track 2: Obstructive Sleep Apnea

Obstructive sleep apnea is a potentially serious sleep disorder. It causes breathing to repeatedly stop and start during sleep. There are several types of sleep apnea, but the most common is obstructive sleep apnea. This type of apnea occurs when the throat muscles intermittently relax and block airway during sleep. A noticeable sign of obstructive sleep apnea is snoring. This occurs when the muscles in the back of throat relax. These muscles support the soft palate, the triangular piece of tissue hanging from the soft palate, the tonsils, the side walls of the throat and the tongue. When the muscles relax, airway narrows or closes as you breathe in. When can't get enough air, which can lower the oxygen level in the blood.

Track 3: Pulmonary Hypertension

Pulmonary hypertension is a type of high blood pressure that affects the arteries in lungs and the right side of heart. In one form of pulmonary hypertension, tiny arteries in lungs called pulmonary arterioles, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through lungs, and raises pressure within lungs' arteries. As the pressure builds, the heart's lower right chamber (right ventricle) must work harder to pump blood through the lungs, eventually causing heart muscle to weaken and fail Each form of Pulmonary hypertension is different, so it is important for newly-diagnosed patients to find a Pulmonary hypertension specialist who can accurately find what is causing their Pulmonary hypertension and develop a treatment plan that is right for that specific type of Pulmonary hypertension as soon as possible. Every person with pulmonary hypertension is different, and new research is being conducted every day with the potential to improve the outlook for people living with this disease. Once in the care of a pulmonary hypertension treating health care team and on appropriate therapy, people with pulmonary hypertension can live many years.

Track 4: Tuberculosis

Tuberculosis is s transferable infection that usually attacks the lungs. It can also spread to other parts of the body, like the brain and spine. A type of bacteria called Mycobacterium tuberculosis causes it. The classic symptoms of active TB are a chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically called "consumption" due to the weight loss. Infection of other organs can cause a wide range of symptoms. Tuberculosis is spread through the air when people who have active TB in their lungs cough, spit, speak, or sneeze. Active infection occurs more often in people with HIV/AIDS and in those who smoke. Diagnosis of active TB is based on chest X-rays, as well as microscopic examination and culture of body fluids. Diagnosis of latent TB relies on the tuberculin skin test (TST) or blood tests Prevention of TB involves screening those at high risk, early detection and treatment of cases, and vaccination with the bacillus Calmette-Guérin (BCG) vaccine. Those at high risk include household, workplace, and social contacts of people with active TB. Treatment requires the use of multiple antibiotics over a long period of time. Antibiotic resistance is a growing problem with increasing rates of multiple drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).

Track 5: Lung Transplantation

Lung transplantation is a surgical procedure in which a patient's diseased lungs are partially or totally replaced by lungs which come from a donor. Donor lungs can be retrieved from a living donor or a deceased donor. A living donor can only donate one lung lobe. With some lung diseases, a recipient may only need to receive a single lung. With other lung diseases such as cystic fibrosis, it is imperative that a recipient receive two lungs. While lung transplants carry certain associated risks, they can also extend life expectancy and enhance the quality of life for end-stage pulmonary patients. Lung damage can often be treated with medication or with special breathing devices. But when these measures no longer lung function becomes life-threatening, doctor might suggest a single-lung transplant or a double-lung transplant. Some people with coronary artery disease may need a procedure to restore blood flow to a blocked or narrowed artery in the heart, in addition to a lung transplant. In some cases, people with serious heart and lung conditions may need a combined heart-lung transplant.

Track 6: Asthma and Allergy

Allergic asthma is asthma caused by an allergic reaction. It’s also known as allergy-induced asthma. People with allergic asthma usually start feeling symptoms after inhaling an allergen such as pollen. The Asthma and Allergy Foundation of America reports that more than half of people with asthma have allergic asthma. Allergic asthma is treatable in most cases. An allergen is a typically harmless substance such as dust mites, pet dander, pollen or mold. If you are allergic to a substance, this allergen triggers a response starting in the immune system. Through a complex reaction, these allergens then cause the passages in the airways of the lungs to become inflamed and swollen. This results in coughing, wheezing and other asthma symptoms The same allergens that give some people sneezing fits and watery eyes can cause an asthma attack in others. Allergic asthma is the most common type of asthma. About 90% of kids with childhood asthma have allergies, compared with about 50% of adults with asthma. The symptoms that go along with allergic asthma show up after you breathe things called allergens like pollen, dust mites, or mold. If you have asthma it usually gets worse after you exercise in cold air or after breathing smoke, dust, or fumes. Sometimes even a strong smell can set it off.

Track 7: Interstitial Lung Disease

Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD) is a group of lung diseases affecting the interstitium the tissue and space around the alveoli. It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process goes awry and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The term Interstitial lung disease is used to distinguish these diseases from obstructive airways diseases. Interstitial lung diseases can be caused by exposure to hazardous chemicals, certain medications and medical treatments. In most cases, the causes are unknown. Lung damage from many ILDs is irreversible and progressive, meaning it gets worse over time. In some cases, it can be slowed by certain medications. Occasionally, people with Interstitial lung disease will be recommended for lung transplants. Prolonged Interstitial lung disease may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified and is associated with typical findings both radiographic and pathologic.

Track 8: Pneumonia

Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia. Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as alveoli. Typically symptoms include some combination of productive or dry cough, chest pain, fever, and trouble breathing. Pneumonia is usually caused by infection with viruses or bacteria and less commonly by other microorganisms, certain medications and conditions such as autoimmune diseases. Risk factors include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, a history of smoking, a poor ability to cough such as following a stroke, and a weak immune system. Diagnosis is often based on the symptoms and physical examination. Chest X-ray, blood tests, and culture of the sputum may help confirm the diagnosis. The disease may be classified by where it was acquired with community, hospital, or health care associated pneumonia

Track 9: Lung Cancer

Lung cancer is a condition that causes cells to divide in the lungs uncontrollably. This causes the growth of tumors that reduce a person's ability to breathe. In lung cancer, this pattern of cell overgrowth occurs in the lungs, which are vital organs for breathing and gas exchange. Cigarette smoking is the principal risk factor for development of lung cancer, Passive exposure to tobacco smoke (passive smoking) also can cause lung cancer in non-smokers. The two types of lung cancer, which grow and spread differently, are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Medical professionals also refer to them as small-cell lung carcinoma and non q-small-cell lung carcinoma. The stage of lung cancer refers to the extent to which the cancer has spread in the body. Treatment of lung cancer can involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy as well as newer experimental methods. The general prognosis of lung cancer is poor because doctors tend not to find the disease until it is at an advanced stage. Five-year survival is around 54% for early stage lung cancer patients that have a tumor localized to the lungs, but only around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most important measure that can prevent the development of lung cancer

Track 10: Pulmonary Rehabilitation

Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is defined by the American Thoracic Society and the European Respiratory Society as an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. In general, pulmonary rehabilitation refers to a series of services that are administered to patients of respiratory disease and their families, typically to attempt to improve the quality of life for the patient. Pulmonary rehabilitation may be carried out in a variety of settings, depending on the patient's needs, and may or may not include pharmacologic intervention. Pulmonary rehabilitation is generally specific to the individual patient, with the objective of meeting the needs of the patient. It is a broad program and may benefit patients with lung diseases such as chronic obstructive pulmonary disease (COPD), sarcoidosis, idiopathic pulmonary fibrosis (IPF) and cystic fibrosis, among others. Although the process is focused on the rehabilitation of the patient him/herself, the family is also involved. The process typically does not begin until a medical exam of the patient has been performed by a licensed physician.

Professors
Ph.D. Scholars and Graduates
Directors and CEO’s of Organizations
Deans and Head of Departments
Nanomaterial societies and associations
Business Delegates and Exhibitors

Mode of Participations:

Speaker
Delegate
Workshops
Poster
Symposiums
Exhibitors Booth and Stalls
Sponsorship
E-Video Presentation
E-poster presentation

Awards:

Best Keynote Speaker Award Model
Organizing Committee Award
Women Scholars
Outstanding Speaker Award
Promising Young Researcher Award
Educative Poster Award

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Watch out for 'feather duvet lung' caution doctors

Dramatic health benefits following air pollution reduction

Deadly 'superbugs' destroyed by molecular drills

Preventing spread of SARS coronavirus-2 in humans

Newsletter